Curated MiRNA

DataTables

MiRNA Compound Condition Effect Throughput PMID Details
miR-22 Cisplatin ovarian cancer Resistant High 19074899
miR-223 Cisplatin ovarian cancer Resistant High 19074899
miR-221 Cisplatin breast cancer Sensitive High 20099276
miR-222 Cisplatin breast cancer Sensitive High 20099276
miR-221 Cisplatin germ cell tumor Sensitive High 21575166
miR-224 Cisplatin Non-small Cell Lung Cancer Sensitive High 21787234
miR-22 Cisplatin ovarian cancer Resistant High 22614869
miR-221 Cisplatin ovarian cancer Resistant High 22614869
miR-222 Cisplatin ovarian cancer Resistant High 22614869
miR-224 Cisplatin ovarian cancer Resistant High 22614869
miR-222 Cisplatin ovarian cancer Sensitive High 23045278
miR-22 Cisplatin hepatocellular cancer Resistant High 23229111
miR-221 Cisplatin osteosarcoma Resistant Low 23372675
miR-22 Cisplatin gastric cancer Sensitive High 23525256
miR-223 Cisplatin breast cancer Sensitive Low 23584479
miR-223 Cisplatin colon cancer Sensitive Low 23584479
miR-223 Cisplatin esophageal adenocarcinoma Sensitive Low 23757351
miR-22 Cisplatin squamous cell carcinoma Resistant High 23831023
miR-221 Cisplatin squamous cell carcinoma Resistant High 23831023
miR-22 Cisplatin osteosarcoma Sensitive Low 24609901
miR-221 Cisplatin ovarian cancer Resistant High 24659709
miR-222 Cisplatin ovarian cancer Resistant High 24659709
miR-224 Cisplatin lung adenocarcinoma Resistant Low 24921914
miR-224 Cisplatin ovarian papillary serous carcinoma Resistant Low 25017423
miR-222 Cisplatin breast cancer Resistant High 25394901
miR-222 Cisplatin oral squamous cell carcinoma Resistant Low 25474084
miR-223 Cisplatin esophageal cancer Sensitive High 26026166
miR-222 Cisplatin small cell lung cancer Sensitive High 26676926
miR-224 Cisplatin small cell lung cancer Sensitive High 26676926